Top Markets
#1 Glidr Glidr +51.75%
#2 Akedo Akedo +48.68%
#3 DOVU DOVU +48.00%
#4 Velvet Velvet +44.04%
#5 Black Phoenix Black Phoenix +34.47%
#6 Ο„emplar Ο„emplar +19.02%
#7 Cross Cross +18.07%
#8 Not in Employment, Education, or Training Not in Employment, Education, or Training +16.92%
#9 Perle Perle +16.73%
#10 Ribbita by Virtuals Ribbita by Virtuals +15.85%
Coin of the day
Glidr Glidr
Settings
Language
ENGLISH
Currency
USD
Theme
Ovoca Bio plc Ovoca Bio plc

Ovoca Bio plc

OVXA
Rank in Stocks #38531
Headquartered in Dublin, Ireland, and established in 1985, Ovoca Bio plc... Headquartered in Dublin, Ireland, and established in 1985, Ovoca Bio plc operates as a clinical-stage biopharmaceutical firm dedicated to discovering and bringing to market innovative therapies for various female sexual dysfunctions. Its primary drug candidate, BP-101, is being developed as a medical treatment for premenopausal women diagnosed with hypoactive sexual desire disorder. This compound is presently in Phase II clinical investigation in Australia and New Zealand, and has progressed to Phase III clinical trials within Russia. Beyond its core pharmaceutical work, the company also participates in mineral exploration and offers supplementary support services. The organization, originally incorporated as Ovoca Gold plc, rebranded to Ovoca Bio plc in July 2018.
Share Price
$0.01142111
Last synced: 2025-03-21
Market Cap
$930.66K
Change (1 day)
0.18%
Change (1 year)
0.00%
Country
IE
Trade Ovoca Bio plc (OVXA)

Category

Healthcare
P/B ratio for Ovoca Bio plc (OVXA)
P/B ratio as of 2026 TTM: 0
According to Ovoca Bio plc latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Ovoca Bio plc from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 -
BE